← Back to Clinical Trials
Recruiting NCT07225023

NCT07225023 A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy for Dizziness

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07225023
Status Recruiting
Phase
Sponsor Northwestern University
Condition Dizziness
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2026-04-01
Primary Completion 2027-07-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Embedded Emergency Department Physical TherapyUsual Care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2026-04-01 with a primary completion date of 2027-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is a multi-site feasibility trial of an embedded emergency department (ED) physical therapy care model for dizziness at two EDs in the Northwestern Medicine and University of Utah Health systems. The study intervention (embedded ED physical therapy) is a reconceptualization of the traditional outpatient physical therapy care model in which we place a physical therapist directly in the ED to initiate timely care for patients with dizziness; we previously evaluated this intervention in a single center randomized trial for low back pain. This multi-site feasibility trial will be comprised of 9 months of active intervention and 12 months of longitudinal data collection. The two sites will be parallel randomized 1:1 to receive either the embedded ED physical therapy condition (intervention, n=1) or usual care (control, n=1) via simple randomization. This trial focuses on feasibility outcomes - such as our ability to enroll participants, deliver the intervention with fidelity, and collect longitudinal patient-reported outcome data and electronic health record data.

Eligibility Criteria

Inclusion Criteria: * Emergency Department (ED) visit with primary diagnosis related to dizziness * ED visit occurring at an ED site participating in randomization (Northwestern Memorial Hospital, University of Utah Hospital) * ED visit check-in time during the hours of 8am-8pm * Age greater than or equal to 18 years; there is no age maximum * English or Spanish-speaking Exclusion Criteria: * Severe neurologic deficit concerning for ischemic or hemorrhagic stroke (i.e., that would necessitate activating a stroke code) * Currently in police custody * Unable to consent * Known pregnancy

Contact & Investigator

Central Contact

Howard Kim, MD, MS

✉ howard.kim@northwestern.edu

📞 312-926-0591

Frequently Asked Questions

Who can join the NCT07225023 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Dizziness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07225023 currently recruiting?

Yes, NCT07225023 is actively recruiting participants. Contact the research team at howard.kim@northwestern.edu for enrollment information.

Where is the NCT07225023 trial being conducted?

This trial is being conducted at Chicago, United States, Salt Lake City, United States.

Who is sponsoring the NCT07225023 clinical trial?

NCT07225023 is sponsored by Northwestern University. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology